Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
121 to 140 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Blood alkaline phosphatase increased | Investigations | 150 mg Abemaciclib + Endocrine Therapy | 83 | 2,791 | 98 |
| other | Blood alkaline phosphatase increased | Investigations | Endocrine Therapy | 47 | 2,800 | 56 |
| other | Blood creatinine increased | Investigations | 150 mg Abemaciclib + Endocrine Therapy | 277 | 2,791 | 396 |
| other | Blood creatinine increased | Investigations | Endocrine Therapy | 17 | 2,800 | 22 |
| other | Gamma-glutamyltransferase increased | Investigations | 150 mg Abemaciclib + Endocrine Therapy | 70 | 2,791 | 80 |
| other | Gamma-glutamyltransferase increased | Investigations | Endocrine Therapy | 24 | 2,800 | 28 |
| other | Weight decreased | Investigations | 150 mg Abemaciclib + Endocrine Therapy | 79 | 2,791 | 88 |
| other | Weight decreased | Investigations | Endocrine Therapy | 19 | 2,800 | 20 |
| other | Weight increased | Investigations | 150 mg Abemaciclib + Endocrine Therapy | 29 | 2,791 | 32 |
| other | Weight increased | Investigations | Endocrine Therapy | 46 | 2,800 | 47 |
| other | Decreased appetite | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 312 | 2,791 | 352 |
| other | Decreased appetite | Metabolism and nutrition disorders | Endocrine Therapy | 54 | 2,800 | 57 |
| other | Dehydration | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 33 | 2,791 | 39 |
| other | Dehydration | Metabolism and nutrition disorders | Endocrine Therapy | 7 | 2,800 | 7 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 49 | 2,791 | 58 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | Endocrine Therapy | 32 | 2,800 | 42 |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 48 | 2,791 | 53 |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | Endocrine Therapy | 61 | 2,800 | 67 |
| other | Hyperglycaemia | Metabolism and nutrition disorders | 150 mg Abemaciclib + Endocrine Therapy | 37 | 2,791 | 51 |
| other | Hyperglycaemia | Metabolism and nutrition disorders | Endocrine Therapy | 43 | 2,800 | 53 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=7